DMAAUDrugs Made In America Acquisition Corp.
11.32USD+3.85%Mkt Cap: P/E:

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business …

Indicators:|

Key Statistics

Company
Market Cap
Enterprise Value356.73M USD
Revenue (TTM)
Gross Profit
Net Income (TTM)5.94M USD
Revenue/Share
Last Price11.32 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees
CountryUS
SectorFinancial Services
IndustryShell Companies
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B-52.65
EPS (TTM)
EPS (Forward)
52W Range
10.2548% of range12.50
52W High12.50 USD
52W Low10.25 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE2.55%
ROA2.48%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-539.19K USD
CapEx (TTM)
FCF Margin
FCF Yield
Net Debt-6.14K USD
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio0.03
Quick Ratio0.02
Book Value/Sh-0.2150 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.29.17M
Float27.31M
Insiders17.88%
Institutions1.54%
Short Interest
Short Ratio16.4d
Shares Short1.50K
Short (prev mo.)1.50K
Technical
SMA 5010.71 (+5.7%)
SMA 20010.56 (+7.2%)
Beta
S&P 52W Chg23.71%
Avg Vol (30d)497
Avg Vol (10d)1.01K
Technical Indicators
RSI (14)99.1
MACD0.0992
MACD Signal0.0368
MACD Hist.+0.0624
BB Upper11.02 USD
BB Middle10.65 USD
BB Lower10.28 USD
BB Width6.98%
ATR (14)0.2349 USD
Vol Ratio (20d)0.00x